INTELLIGENCE IN ACTION

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

June 19, 2019

Anyone who works in health IT knows how gratifying it is when we offer clinicians a tool that is so much better than old processes, and they run with it. And it’s especially transformative when technology replaces a manual process—one that absorbed a great deal of time and resources.

This is the case with medication prior authorization. The manual version is burdensome, unreliable and often causes patients to wait to pick up their needed prescriptions. The electronic version is better, faster and helps ensure that the medication is filled and waiting at the pharmacy as expected.

Read the press release: Health Plans and Pharmacy Benefit Managers Leverage Technology to Streamline Medication Prior Authorization for Virtually All U.S. Patients

While manual prior authorization is far from ideal, it does serve an essential purpose in healthcare. It is an important tool in managing things like opioid abuse. And it helps leverage health plan benefits efficiently to ensure quality care, reduce healthcare waste and control costs.

Last year, provider adoption of Electronic Prior Authorization grew by 128%, and transactions increased by 172% nationwide. Over the past 18 months, several national, regional and local PBMs and health plans have signed on, increasing the number of insured lives covered by nearly 20%.

The collaboration among participants in the Surescripts Network Alliance™ means that virtually all patients can get their medications quicker and with less hassle. And for those of us in health IT, it’s the perfect case study for what happens when we align our resources at the intersection of innovation and patient care.

Related Articles

May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...
April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Healthcare costs are increasingly prohibitive for too many Americans, and these costs can hit older Americans especially hard. That’s why we applaud the Centers for Medicare & Medicaid Services (CMS) proposed rule on real-time benefit tools (RTBT). Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX